generics | WRAL TechWire


United Therapeutics settles patent suit over $157M hypertension drug

United Therapeutics (Nasdaq:UTHR) has settled its patent suit with Actavis Labortories, FL, a subsidiary of Teva Pharmaceuticals, over patents related to its hyptension drug Orenitram. The drug brought in more than $157 million to United Therapeutics in 2016. The settlement lets Actavis make and commercialize a generic version of...

Read More